These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 12495365)

  • 1. Defining the role of the caregiver in Alzheimer's disease treatment.
    Brodaty H; Green A
    Drugs Aging; 2002; 19(12):891-8. PubMed ID: 12495365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between physician and caregiver evaluations in Alzheimer's disease.
    Sinforiani E; Pasotti C; Chiapella L; Malinverni P; Zucchella C
    Funct Neurol; 2010; 25(4):205-9. PubMed ID: 21388581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
    Saint-Laurent Thibault C; Özer Stillman I; Chen S; Getsios D; Proskorovsky I; Hernandez L; Dixit S
    J Med Econ; 2015; 18(11):930-43. PubMed ID: 26086535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the effects of memantine on clinical progression in Alzheimer's disease.
    Wilkinson D
    Int J Geriatr Psychiatry; 2012 Aug; 27(8):769-76. PubMed ID: 21964871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():21. PubMed ID: 14579479
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduction of caregiver burden in Alzheimer's disease by treatment with galantamine.
    Kaufer DI; Borson S; Kershaw P; Sadik K
    CNS Spectr; 2005 Jun; 10(6):481-8. PubMed ID: 15908902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease--towards more patient-centred and meaningful clinical outcomes.
    Chin JJ
    Ann Acad Med Singap; 2008 Jul; 37(7):535-7. PubMed ID: 18695763
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease.
    Doody R; Wirth Y; Schmitt F; Möbius HJ
    Dement Geriatr Cogn Disord; 2004; 18(2):227-32. PubMed ID: 15256834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of memantine in the treatment of Alzheimer's disease].
    Molinuevo Guix JL; Lladó Plarrumaní A
    Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease.
    Cummings JL
    N Engl J Med; 2004 Jul; 351(1):56-67. PubMed ID: 15229308
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment, measures and approaches to easing caregiver burden in Alzheimer's disease.
    Farcnik K; Persyko MS
    Drugs Aging; 2002; 19(3):203-15. PubMed ID: 12027778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients?
    Sevilla C; Jiménez Caballero PE; Alfonso V; González-Adalid M
    Dement Geriatr Cogn Disord; 2009; 28(3):196-205. PubMed ID: 19738386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN
    J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
    Schölzel-Dorenbos CJ;
    Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer's disease.
    Davis KL; Marin DB; Kane R; Patrick D; Peskind ER; Raskind MA; Puder KL
    Int J Geriatr Psychiatry; 1997 Oct; 12(10):978-88. PubMed ID: 9395929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease.
    Rabins PV; Lyketsos CG
    Nat Clin Pract Neurol; 2006 Nov; 2(11):578-9. PubMed ID: 17057739
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of galantamine treatment on caregiver time in Alzheimer's disease.
    Sano M; Wilcock GK; van Baelen B; Kavanagh S
    Int J Geriatr Psychiatry; 2003 Oct; 18(10):942-50. PubMed ID: 14533127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
    Grossberg GT; Edwards KR; Zhao Q
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memantine in moderate-to-severe Alzheimer's disease.
    Reisberg B; Doody R; Stöffler A; Schmitt F; Ferris S; Möbius HJ;
    N Engl J Med; 2003 Apr; 348(14):1333-41. PubMed ID: 12672860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world evaluation of compliance and preference in Alzheimer's disease treatment.
    Pai MC; Aref H; Bassil N; Kandiah N; Lee JH; Srinivasan AV; diTommaso S; Yuksel O
    Clin Interv Aging; 2015; 10():1779-87. PubMed ID: 26622172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.